Regenxbio
RGNX
RGNX
165 hedge funds and large institutions have $894M invested in Regenxbio in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 61 increasing their positions, 56 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
22% less capital invested
Capital invested by funds: $1.15B → $894M (-$259M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
54% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 37
Holders
165
Holding in Top 10
1
Calls
$3.42M
Puts
$2.51M
Top Buyers
| 1 | +$9.41M | |
| 2 | +$7.37M | |
| 3 | +$7.36M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$7.1M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$4.73M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$7.25M | |
| 3 | -$5.2M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$3.36M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
-$2.99M |